Regencell Bioscience Holdings Ltd (RGC) › Operating Cash FlowRegencell Bioscience Holdings Ltd (RGC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$391.0K2020: -$726.6K2021: -$767.3K2022: -$5.27M2023: -$4.96M2024: -$4.00M2025: -$3.11M-$3.11M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$3.11M+22.2%2024-$4.00M+19.4%2023-$4.96M+5.8%2022-$5.27M-586.4%2021-$767.3K-5.6%2020-$726.6K-85.8%2019-$391.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share